A bill to amend the Controlled Substances Act to more effectively regulate selective androgen receptor modulators, and for other purposes.
Selective Androgen Receptor Modulators Control Act of 2018 or the SARMs Control Act of 2018
This bill amends the Controlled Substances Act (CSA) to add SARMs (selective androgen receptor modulators) to schedule III. A SARM is a synthetic drug or substance that has effects similar to testosterone. A schedule III controlled substance (e.g., an anabolic steroid) has less potential for abuse than a schedule I or II substance, has a currently accepted medical use, and has low or moderate risk of dependence if abused.
The bill also:
The bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to notify the DEA when it determines that a new dietary ingredient in a dietary supplement may contain a SARM or SARM analogue.
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line